skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Covid-19 Vaccines remover assunto: Disease Transmission remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
Material Type:
Artigo 		Adicionar ao Meu Espaço

SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact

Lipsitch, Marc ; Krammer, Florian ; Regev-Yochay, Gili ; Lustig, Yaniv ; Balicer, Ran D

Nature reviews. Immunology, 2022-01, Vol.22 (1), p.57-65 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

Sadoff, Jerald ; Gray, Glenda ; Vandebosch, An ; Cárdenas, Vicky ; Shukarev, Georgi ; Grinsztejn, Beatriz ; Goepfert, Paul A ; Truyers, Carla ; Fennema, Hein ; Spiessens, Bart ; Offergeld, Kim ; Scheper, Gert ; Taylor, Kimberly L ; Robb, Merlin L ; Treanor, John ; Barouch, Dan H ; Stoddard, Jeffrey ; Ryser, Martin F ; Marovich, Mary A ; Neuzil, Kathleen M ; Corey, Lawrence ; Cauwenberghs, Nancy ; Tanner, Tamzin ; Hardt, Karin ; Ruiz-Guiñazú, Javier ; Le Gars, Mathieu ; Schuitemaker, Hanneke ; Van Hoof, Johan ; Struyf, Frank ; Douoguih, Macaya

The New England journal of medicine, 2021-06, Vol.384 (23), p.2187-2201 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
3
Considerations in boosting COVID-19 vaccine immune responses
Considerations in boosting COVID-19 vaccine immune responses
Material Type:
Artigo 		Adicionar ao Meu Espaço

Considerations in boosting COVID-19 vaccine immune responses

Krause, Philip R ; Fleming, Thomas R ; Peto, Richard ; Longini, Ira M ; Figueroa, J Peter ; Sterne, Jonathan A C ; Cravioto, Alejandro ; Rees, Helen ; Higgins, Julian P T ; Boutron, Isabelle ; Pan, Hongchao ; Gruber, Marion F ; Arora, Narendra ; Kazi, Fatema ; Gaspar, Rogerio ; Swaminathan, Soumya ; Ryan, Michael J ; Henao-Restrepo, Ana-Maria

The Lancet (British edition), 2021-10, Vol.398 (10308), p.1377-1380 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
Material Type:
Artigo 		Adicionar ao Meu Espaço

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection

Hall, Victoria ; Foulkes, Sarah ; Insalata, Ferdinando ; Kirwan, Peter ; Saei, Ayoub ; Atti, Ana ; Wellington, Edgar ; Khawam, Jameel ; Munro, Katie ; Cole, Michelle ; Tranquillini, Caio ; Taylor-Kerr, Andrew ; Hettiarachchi, Nipunadi ; Calbraith, Davina ; Sajedi, Noshin ; Milligan, Iain ; Themistocleous, Yrene ; Corrigan, Diane ; Cromey, Lisa ; Price, Lesley ; Stewart, Sally ; de Lacy, Elen ; Norman, Chris ; Linley, Ezra ; Otter, Ashley D ; Semper, Amanda ; Hewson, Jacqueline ; D’Arcangelo, Silvia ; Chand, Meera ; Brown, Colin S ; Brooks, Tim ; Islam, Jasmin ; Charlett, Andre ; Hopkins, Susan

The New England journal of medicine, 2022-03, Vol.386 (13), p.1207-1220 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
5
Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
Material Type:
Artigo 		Adicionar ao Meu Espaço

Model-informed COVID-19 vaccine prioritization strategies by age and serostatus

Bubar, Kate M ; Reinholt, Kyle ; Kissler, Stephen M ; Lipsitch, Marc ; Cobey, Sarah ; Grad, Yonatan H ; Larremore, Daniel B

Science (American Association for the Advancement of Science), 2021-02, Vol.371 (6532), p.916-921 [Periódico revisado por pares]

United States: The American Association for the Advancement of Science

Texto completo disponível

Citações Citado por
6
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

Monin, Leticia ; Laing, Adam G ; Muñoz-Ruiz, Miguel ; McKenzie, Duncan R ; del Molino del Barrio, Irene ; Alaguthurai, Thanussuyah ; Domingo-Vila, Clara ; Hayday, Thomas S ; Graham, Carl ; Seow, Jeffrey ; Abdul-Jawad, Sultan ; Kamdar, Shraddha ; Harvey-Jones, Elizabeth ; Graham, Rosalind ; Cooper, Jack ; Khan, Muhammad ; Vidler, Jennifer ; Kakkassery, Helen ; Sinha, Shubhankar ; Davis, Richard ; Dupont, Liane ; Francos Quijorna, Isaac ; O'Brien-Gore, Charlotte ; Lee, Puay Ling ; Eum, Josephine ; Conde Poole, Maria ; Joseph, Magdalene ; Davies, Daniel ; Wu, Yin ; Swampillai, Angela ; North, Bernard V ; Montes, Ana ; Harries, Mark ; Rigg, Anne ; Spicer, James ; Malim, Michael H ; Fields, Paul ; Patten, Piers ; Di Rosa, Francesca ; Papa, Sophie ; Tree, Timothy ; Doores, Katie J ; Hayday, Adrian C ; Irshad, Sheeba

The lancet oncology, 2021-06, Vol.22 (6), p.765-778 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Collier, Dami A ; De Marco, Anna ; Ferreira, Isabella A T M ; Meng, Bo ; Datir, Rawlings P ; Walls, Alexandra C ; Kemp, Steven A ; Bassi, Jessica ; Pinto, Dora ; Silacci-Fregni, Chiara ; Bianchi, Siro ; Tortorici, M Alejandra ; Bowen, John ; Culap, Katja ; Jaconi, Stefano ; Cameroni, Elisabetta ; Snell, Gyorgy ; Pizzuto, Matteo S ; Pellanda, Alessandra Franzetti ; Garzoni, Christian ; Riva, Agostino ; Elmer, Anne ; Kingston, Nathalie ; Graves, Barbara ; McCoy, Laura E ; Smith, Kenneth G C ; Bradley, John R ; Temperton, Nigel ; Ceron-Gutierrez, Lourdes ; Barcenas-Morales, Gabriela ; Harvey, William ; Virgin, Herbert W ; Lanzavecchia, Antonio ; Piccoli, Luca ; Doffinger, Rainer ; Wills, Mark ; Veesler, David ; Corti, Davide ; Gupta, Ravindra K

Nature (London), 2021-05, Vol.593 (7857), p.136-141 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy
Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy

Giordano, Giulia ; Colaneri, Marta ; Di Filippo, Alessandro ; Blanchini, Franco ; Bolzern, Paolo ; De Nicolao, Giuseppe ; Sacchi, Paolo ; Colaneri, Patrizio ; Bruno, Raffaele

Nature medicine, 2021-06, Vol.27 (6), p.993-998 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
How bad is Omicron? What scientists know so far
How bad is Omicron? What scientists know so far
Material Type:
Artigo 		Adicionar ao Meu Espaço

How bad is Omicron? What scientists know so far

Callaway, Ewen ; Ledford, Heidi

Nature (London), 2021-12, Vol.600 (7888), p.197-199 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study

Shrotri, Madhumita ; Krutikov, Maria ; Palmer, Tom ; Giddings, Rebecca ; Azmi, Borscha ; Subbarao, Sathyavani ; Fuller, Christopher ; Irwin-Singer, Aidan ; Davies, Daniel ; Tut, Gokhan ; Lopez Bernal, Jamie ; Moss, Paul ; Hayward, Andrew ; Copas, Andrew ; Shallcross, Laura

The Lancet infectious diseases, 2021-11, Vol.21 (11), p.1529-1538 [Periódico revisado por pares]

United States: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (8.016)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (8.720)
  2. Artigos de Jornal  (1.571)
  3. magazinearticle  (380)
  4. Reports  (38)
  5. Resenhas  (9)
  6. Anais de Congresso  (3)
  7. Newsletter Articles  (1)
  8. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2019  (1)
  2. 2019Até2019  (1)
  3. 2020Até2020  (454)
  4. 2021Até2022  (7.174)
  5. Após 2022  (3.093)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (10.717)
  2. Japonês  (335)
  3. Português  (32)
  4. Francês  (17)
  5. Alemão  (8)
  6. Chinês  (8)
  7. Espanhol  (7)
  8. Norueguês  (6)
  9. Africâner  (6)
  10. Turco  (3)
  11. Polonês  (1)
  12. Italiano  (1)
  13. Croatian  (1)
  14. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.